跳转至内容
Merck
CN
所有图片(1)

文件

MAB8694

Sigma-Aldrich

Anti-Hepatitis C Virus Antibody, NS5A

Chemicon®, from mouse

别名:

HCV

登录查看公司和协议定价


About This Item

UNSPSC代码:
12352203
eCl@ss:
32160702
NACRES:
NA.41

生物来源

mouse

质量水平

抗体形式

purified immunoglobulin

抗体产品类型

primary antibodies

克隆

monoclonal

种属反应性

human

制造商/商品名称

Chemicon®

技术

ELISA: suitable
immunofluorescence: suitable
immunohistochemistry: suitable
western blot: suitable

同位素/亚型

IgG1

运输

wet ice

特异性

Specific to HCV NS5A

免疫原

Recombinant protein to NS5A

应用

ELISA

Immunofluorescence

RIA

Western Blot

Optimal working dilutions must be determined by end user.
Research Category
Infectious Diseases
Research Sub Category
Infectious Diseases - Viral
This Anti-Hepatitis C Virus Antibody, NS5A is validated for use in ELISA, IF, WB, IH for the detection of Hepatitis C Virus.

外形

Format: Purified
Liquid 0.02M PB, 0.25M NaCl, 0.1% sodium azide

储存及稳定性

Store at 2 to 8°C for up to 12 months from date of receipt.

法律信息

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

免责声明

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Not finding the right product?  

Try our 产品选型工具.

WGK

WGK 2

闪点(°F)

Not applicable

闪点(°C)

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Inhibition of hepatitis C virus (HCV) replication by specific RNA aptamers against HCV NS5B RNA replicase.
Lee, CH; Lee, YJ; Kim, JH; Lim, JH; Kim, JH; Han, W; Lee, SH; Noh, GJ; Lee, SW
Journal of virology null
Azhar Mehmood et al.
Viral immunology, 30(8), 568-575 (2017-09-06)
Hepatitis C Virus (HCV) infection is a major health concern worldwide. The presence of both HCV viral RNA and NS5A proteins in peripheral blood mononuclear cells (PBMCs) indicate the efficacy of the treatment during sustained virological response (SVR) and end
Hepatitis C virus replication-specific inhibition of microRNA activity with self-cleavable allosteric ribozyme.
Chang Ho Lee,Ji Hyun Kim,Hee Won Kim,Heejoon Myung,Seong-Wook Lee
Nucleic Acid Therapeutics null
Enhanced Ca2+ leak from ER Ca2+ stores induced by hepatitis C NS5A protein.
Lisbeth C Robinson, Jonathan S Marchant, Lisbeth C Robinson, Jonathan S Marchant
Biochemical and biophysical research communications null
Chang Ho Lee et al.
Molecular therapy. Nucleic acids, 4, e254-e254 (2015-10-07)
Hepatitis C virus (HCV) is the major cause of progressive liver disease such as chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Previously, we reported that a 29 nucleotide-long 2'-F pyrimidine modified RNA aptamer against the HCV nonstructural protein 5B efficiently inhibited

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门